Key facts
- This page summarizes Harold E. Brakewood's Form 4 filing for Immuneering Corp (IMRX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Jan 2026, 09:09.
Harold E. Brakewood - 16 Jan 2026 Form 4 Insider Report for Immuneering Corp (IMRX)
- Reporting relationship
- Chief Business Officer
- Issuer ticker
- IMRX
- Reported as of
- 16 Jan 2026
- Net transaction value
- +$24,990
- SEC form
- 4
- Accepted by SEC
- 21 Jan 2026, 09:09:57 UTC
- Prior SEC filing
- 24 Jun 2025
- Next SEC filing
- 05 Feb 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael D. Bookman, Attorney-in-Fact for Harold E. Brakewood
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Harold E. Brakewood filed Form 4 for Immuneering Corp (IMRX) on 21 Jan 2026.
Change
- Previous filing in this sequence was filed on 24 Jun 2025.
- Current net transaction value: +$24,990.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001969578
Primary reporting owner
Brakewood Harold Eugene
- Relationship
- Chief Business Officer
- Address
- C/O IMMUNEERING CORPORATION, 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE
- Signature
- /s/ Michael D. Bookman, Attorney-in-Fact for Harold E. Brakewood
- Signature date
- 21 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IMRX
transaction
Class A Common Stock
Purchase
- Transaction value
- $24,990
- Shares
- +5,250
- Change %
- +91%
- Price
- $4.76
- Shares after
- 11,050
- Date
- 16 Jan 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.